Cargando…
Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
Background: Neuroimaging shows considerable promise in generating sensitive and objective outcome measures for therapeutic trials across a range of neurodegenerative conditions. For volumetric measures the current gold standard is manual delineation, which is unfeasible for samples sizes required fo...
Autores principales: | Mansoor, Nina M., Vanniyasingam, Tishok, Malone, Ian, Hobbs, Nicola Z., Rees, Elin, Durr, Alexandra, Roos, Raymund A. C., Landwehrmeyer, Bernhard, Tabrizi, Sarah J., Johnson, Eileanoir B., Scahill, Rachael I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079754/ https://www.ncbi.nlm.nih.gov/pubmed/33935934 http://dx.doi.org/10.3389/fneur.2021.616272 |
Ejemplares similares
-
Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease
por: Johnson, Eileanoir B., et al.
Publicado: (2017) -
Neurofilament light protein in blood predicts regional atrophy in Huntington disease
por: Johnson, Eileanoir B., et al.
Publicado: (2018) -
Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study()
por: Hobbs, Nicola Z., et al.
Publicado: (2012) -
Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023) -
Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)